Natur Produkt Pharmasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-01-16
Share capital
2 652 300,00 PLN
Registered address
Podstoczysko 30, 07-300 Ostrów Mazowiecka, Poland
Electronic delivery address
AE:PL-93284-13861-DEIHD-28

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 93.85mMedianUSD 782.27kAverageUSD 24.03m
Net profit
This companyUSD 13.46mMedianUSD 7.91kAverageUSD 2.59m
Operating costs
This companyUSD 76.57mMedianUSD 723.93kAverageUSD 19.92m
Assets
This companyUSD 63.43mMedianUSD 800.34kAverageUSD 29.11m

Bank accounts

Registered as a VAT taxpayer on 1996-07-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$1.3M
Buildings and premises
$4.8M

Public aid

42 public aid cases recorded, with a total value of $510,865.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$16,230
De minimis aid (in accordance with Commission Regulation 2023/2831)
$11,504
De minimis aid (in accordance with Commission Regulation 2023/2831)
$5,003

European Funds

ProjectEU co-financing
Przeprowadzenie prac badawczo-rozwojowych w celu opracowania nowych suplementów diety o zwiększonym bezpieczeństwie ich stosowania zawierających ekstrakty roślinne
$163.0K

Tenders

No recorded participation in tenders.

Trademarks

Natur Produkt Pharma holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2018.

MarkProtected until
GMPAug 31, 2028

Regulatory authorisations

AuthorityTypeStatus
Waste generation Active

Authorized Representatives

Guido Colsman – Vice President of the Management Board
Jarosław Paweł Purwin – President of the Management Board
Katarzyna Mażewska Wojtaś – Attorney-in-fact (joint)
Marc Kruger – Vice President of the Management Board
Krystyna Nowak – Vice President of the Management Board

Manner of representation

Two members of the management board jointly, or one member of the management board together with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Kruger Beteiligungsgesellschaft Mbh
1,263$358,225.2850%
1,263$358,225.2850%

Beneficial owners

Person

Competitors

Name
Anpharm Przedsiębiorstwo FarmaceutyczneS.A.
Tarchomińskie Zakłady Farmaceutyczne PolfaS.A.
BiotonS.A.
Celon PharmaS.A.
VercoS.A.
VipharmS.A.
MedicofarmaS.A.
VitamaS.A.
Munar PharmaS.A.
Sanford Biotechsp. z o.o.

Change history

DateEvent
2016-05-13PKD change
2011-03-24PKD change
2003-01-16Entered in the register

FAQ

Last updated: 2026-10-07